Skip to main content
Abpro Bio Co., Ltd. logo

Abpro Bio Co., Ltd. — Investor Relations & Filings

Ticker · 195990 ISIN · KR7195990007 KO Manufacturing
Open in API
Filings indexed 430 across all filing types
Latest filing 2026-04-15 Regulatory Filings
Country KR South Korea
Listing KO 195990

About Abpro Bio Co., Ltd.

https://abpro.co/

Abpro Bio Co., Ltd. is a company engaged in the manufacture and sale of precision machine tools. Its primary products include tapping centers, 2-spindle machining centers, and other specialized industrial machinery. In addition to its core manufacturing operations, the company has diversified its business to include a biotechnology division. This division is involved in the development of next-generation antibody therapeutics, often through exclusive development agreements and collaborations with strategic partners.

Recent filings

Filing Released Lang Actions
기타시장안내(최대주주의의무보유관련) (최대주주의 의무보유 이행 관련)
Regulatory Filings Classification · 75% confidence The document is a brief market notice to the stock exchange (KOSDAQ) confirming the major shareholder’s completion of a one‐year mandatory lock‐up for newly issued shares. It is not an AGM material, earnings release, or detailed financial report but a regulatory disclosure. It provides substantive content (confirmation of lock‐up) rather than simply announcing publication of a report. This fits the fallback category “Regulatory Filings (RNS).”
2026-04-15 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 88% confidence The document is a Korean ‘주요사항보고서’ (Material Information Report) concerning the issuance (and correction) of convertible bonds by AB Pro Bio. It details terms of the bond, conversion rights, maturity, early redemption options, and corrections to previously filed dates. This is a financing activity—specifically the issuance of debt (convertible bonds)—and not an annual report, earnings release, management change, or other category. Under the defined categories, this best fits “Capital/Financing Update” (CAP).
2026-04-10 Korean
주주총회소집결의 (임시주주총회)
Regulatory Filings Classification · 85% confidence The document is a Korean notice of convocation of an extraordinary shareholders’ meeting (임시주주총회). It provides meeting date, time, location, record date, and board resolution date. It is a short announcement (under 5,000 characters) and simply communicates the convening details without containing the full proxy statement or material itself. There is no detailed proxy solicitation or attached report; thus it does not fit fully into ‘Proxy Solicitation & Information Statement (PSI)’. It falls under the general regulatory announcement category as a convening notice. Therefore, it is best classified as a Regulatory Filing (RNS).
2026-04-10 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 80% confidence The document is an official announcement by a company (in Korean) setting the record date (기준일) and closure period for the shareholders’ register in preparation for an Extraordinary General Meeting. This is a regulatory announcement that does not fall under specific categories like dividend notices, capital changes, or financial reports. Therefore it is classified under the fallback category Regulatory Filings (RNS).
2026-04-10 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 85% confidence The document is a Korean "임원ㆍ주요주주 특정증권등 소유상황보고서" filed with the Securities and Futures Commission and Korea Exchange, detailing the number and percentage of shares held by a major shareholder (Returns Co., Ltd.) in AB Pro Bio and reporting an acquisition on 2026-04-01 that raises its stake to 12.61%. This is a statutory notification of a major shareholding and change in ownership percentage crossing a regulatory threshold. Therefore it fits the “Major Shareholding Notification” category (MRQ).
2026-04-08 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 90% confidence The document is a disclosure under Korea’s Capital Markets Act (Article 147) titled “주식등의 대량보유상황보고서(일반)” which translates to a “Large Shareholding Report (General).” It details the number of shares, percentage holdings, acquisition method, counterparty, and funding sources for a substantial shareholding (over 12.61%) by Returns Co., Ltd. into AB ProBio. This falls squarely into our “Major Shareholding Notification” category (MRQ).
2026-04-08 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.